Literature DB >> 31265588

Erratum: Human Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients: Erratum.

.   

Abstract

[This corrects the article DOI: 10.1097/MD.0000000000003064.].

Entities:  

Year:  2016        PMID： 31265588      PMCID： PMC4902446          DOI： 10.1097/01.md.0000484044.28366.8c

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN： 0025-7974            Impact factor:   1.889


In the article “Human Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients”,[1] which appeared in Volume 95, Issue 11 of Medicine, an error was detected in Table 1. The article has since been corrected online.
  1 in total

1.  Human Cytokine Genetic Variants Associated With HBsAg Reverse Seroconversion in Rituximab-Treated Non-Hodgkin Lymphoma Patients.

Authors:  Liang-Tsai Hsiao; Hao-Yuan Wang; Ching-Fen Yang; Tzeon-Jye Chiou; Jyh-Pyng Gau; Yuan-Bin Yu; Hsiao-Ling Liu; Wen-Chun Chang; Po-Min Chen; Cheng-Hwai Tzeng; Yu-Jiun Chan; Muh-Hwa Yang; Jin-Hwang Liu; Yi-Hsiang Huang
Journal:  Medicine (Baltimore)       Date:  2016-03       Impact factor: 1.889
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.